Suzanne Bujara

Contributing Writer https://www.psychiatryadvisor.com

Suzanne Bujara is a medical writer with more than 20 years of experience. She writes for continuing medical education and public health programs. She has a BA in linguistics from Douglass College, Rutgers, The State University of New Jersey and an MBA from Rutgers Business School. Before starting her freelance business in 2016, Suzanne wrote for Medscape Education, myCME, praxis.md, and Medical Economics magazine. To learn more about Suzanne, visit www.suzannebujara.com and www.linkedin.com/in/suzannebujara.

All articles by Suzanne Bujara

Depression Advisor, Uncategorized

Treatments for Resynchronization in Sleep and Depression

Suzanne Bujara

July 3, 2019

Researchers found data that show adverse lifestyle factors increase the risk for depression.

Depression Advisor

Sensible Strategies to Overcome Barriers to Depression Treatment

Suzanne Bujara

June 19, 2019

Researcher data showed that the boundaries to successful treatment in depression in patients who are minorities are varied, but that there are certain predisposing factors such as adverse childhood events and genetics.

Schizophrenia Advisor

Early Stresses Contribute to Schizophrenia

Suzanne Bujara

April 16, 2019

Researchers found data to support their hypothesis that developmental stress vulnerability is the link between a predisposition and environmental triggers in the pathophysiology of schizophrenia.

Depression Advisor

Targeting Inflammation Through Cytokines to Treat Depressive Symptoms

Suzanne Bujara

February 20, 2019

Researchers found a small number of clinical trials that indicated antidepressant effects of cytokine blockers.

General Psychiatry

Social Support Prevents Further Distress in Victims of Violence

Suzanne Bujara

February 8, 2019

Researchers found that the inclusion of significant others in cognitive behavioral therapy for victims of violent crimes is beneficial for the victim and indirect victim.

Depression Advisor

Brain-Derived Neurotrophic Factor: An Effective Biomarker for ECT Response in MDD?

Suzanne Bujara

January 24, 2019

Researchers found no association between depression severity and brain-derived neurotrophic factor (BDNF) levels, and no correlation between BDNF levels and response to electroconvulsive therapy.

Schizophrenia and Psychoses

Schizophrenia Add-Ons: Beware the Flawed Meta-Analyses Touting Improvements

Suzanne Bujara

January 8, 2019

Clinicians should be discerning when evaluating meta-analyses of schizophrenia add-on therapies such as statins and antidepressants.

Bipolar Disorder

Long-Term Lithium Use: More Evidence Needed to Associate With Cancer Risk

Suzanne Bujara

December 13, 2018

The European Medicine Agency has reported that there may be an association between long-term lithium use and reports of both renal tumors and thyroid cancer.

Schizophrenia Advisor

Schizophrenia Therapy Adherence Tied to Patients’ Beliefs

Suzanne Bujara

October 26, 2018

Given the substantial burden of nonadherence to therapy in patients with schizophrenia, new interventions for compliance are critical.

Depression Advisor

Predicting Poststroke Depression: Biomarkers and Beyond

Suzanne Bujara

October 15, 2018

As depression is one of the most common psychiatric disorders following acute stroke and can be predictive of poor outcomes, identifying biomarkers to recognize the disorder are imperative for improving the clinical course.

Next post in Depression Advisor